|
Volumn 4, Issue 3, 2015, Pages 284-286
|
Interferon beta related pulmonary arterial hypertension; An emerging worrying entity?
|
Author keywords
Relapsing remitting multiple sclerosis; Treatment; Treatment side effects
|
Indexed keywords
ALKALINE PHOSPHATASE;
AMBRISENTAN;
AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;
ANTICOAGULANT AGENT;
BETA1A INTERFERON;
DIURETIC AGENT;
GAMMA GLUTAMYLTRANSFERASE;
GLATIRAMER;
SILDENAFIL;
BETA INTERFERON;
IMMUNOLOGIC FACTOR;
ADULT;
ARTICLE;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
DYSPNEA;
ECHOCARDIOGRAPHY;
FEMALE;
HEART PALPITATION;
HEART SOUND;
HUMAN;
LUNG BLOOD VESSEL;
MEAN ARTERIAL PRESSURE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
OXYGEN DESATURATION;
PULMONARY HYPERTENSION;
RELAPSE;
SINUS TACHYCARDIA;
TRICUSPID VALVE REGURGITATION;
WALKING;
CHEMICALLY INDUCED;
COMPLICATION;
HYPERTENSION, PULMONARY;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
FEMALE;
HUMANS;
HYPERTENSION, PULMONARY;
IMMUNOLOGIC FACTORS;
INTERFERON-BETA;
MIDDLE AGED;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
|
EID: 84930181614
PISSN: 22110348
EISSN: 22110356
Source Type: Journal
DOI: 10.1016/j.msard.2015.03.008 Document Type: Article |
Times cited : (15)
|
References (6)
|